Skip to main content

Table 2 Vaccine scenarios for the 2-strain model

From: The impact of aggregating serogroups in dynamic models of Neisseria meningitidis transmission

2-strain Vaccine Scenarios

 

Age of Immunization

Vaccine Type

Efficacy

Coverage

10

12 months

C

97 %

90 %

11

12 years

C

97 %

80 %

12

12 months and 12 years

C

97 %

90 %/80 %

13

12 months

4CMenB

64 %

90 %

14

12 years

4CMenB

64 %

80 %

15

12 months and 12 years

4CMenB

64 %

90 %/80 %

  1. The efficacy of the conjugate C vaccine is 97 % [46]. The 4CMenB vaccine efficacy is assumed to be 64 % based on [44]. The duration of vaccine protection is assumed to be 4 years
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us